Geoffrey Parker sold $49K of Allogene Therapeutics stock
By AlphaYouPublished Form 4
Parker Geoffrey M.
Reporting filer
Geoffrey Parker reported selling 36,342 shares of Allogene Therapeutics, Inc. for about $49K ($1.34 a share on average). Form 4 filed Oct 23, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 23, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Parker Geoffrey M. | 2026-10-21 | S | Sale | 36342 | 1.34 | 1,045,877 | 2 days | Filed terms
|
Common Stock
- Owner
- Parker Geoffrey M.
- Date
- 2026-10-21
- Code
- S
- Action
- Sale
- Quantity
- 36342
- Price
- 1.34
- Following holdings
- 1,045,877
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-21
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 36342
- id: F1
- transaction Price Per Share: 1.34
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 1045877
- id: F2
- id: F3
- id: F4
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Parker Geoffrey M.: CHIEF FINANCIAL OFFICER.
- F1: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- F2: Reflects forfeiture of 195,000 shares subject to performance RSUs granted to the Reporting Person on October 10, 2023.
- F3: Includes 12,500 shares of the Issuer's common stock acquired by the reporting person on March 15, 2026 pursuant to an employee stock purchase program.
- F4: Includes 11,924 shares of the Issuer's common stock acquired by the reporting person on September 15, 2026 pursuant to an employee stock purchase program.
Original sources
Prepared automatically from public filing data. Report a correction.